# SNTI (Senti Biosciences Holdings, Inc.) - SEC EDGAR Financial Statements

> Senti Biosciences Holdings, Inc. reported $74K in revenue and a net loss of $43.02M for the trailing twelve months ended September 30, 2026, with a -67652.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/SNTI
- Markdown: https://convexityos.com/fundamentals/SNTI.md
- SEC CIK: 0001854270
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001854270&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $74K | Sep 30, 2026 |
| Operating Income | TTM | -$50.06M | -67652.7% margin |
| Net Income | TTM | -$43.02M | -58140.5% net margin |
| Diluted EPS | TTM | -$1.38 | Split-adjusted |
| Free Cash Flow | TTM | -$43.64M | -58973.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $5.55M | Total debt: $15.27M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $22K | $0 | $2.56M | $4.29M | $2.76M |
| Research & Development | $37.59M | $34.36M | $32.15M | $28.14M | $21.96M |
| Total Operating Expenses | $68.80M | $61.04M | $95.29M | $66.37M | $43.21M |
| **Operating Income** | -$68.78M | -$61.04M | -$92.73M | -$62.08M | -$40.45M |
| **EBITDA** | -$65.14M | -$57.20M | -$89.17M | -$60.68M | -$39.68M |
| Income Tax Expense | $0 | $0 | -- | -- | -- |
| **Net Income** | -$61.44M | -$52.79M | -$71.06M | -$58.21M | -$55.32M |
| Basic EPS | -$2.73 | -$12.03 | -$16.01 | -$22.30 | -$190.00 |
| **Diluted EPS** | -$2.73 | -$12.03 | -$16.01 | -$22.30 | -$190.00 |
| Basic Shares Outstanding | 22.5M | 4.6M | 4.4M | 2.6M | 291.2K |
| Diluted Shares Outstanding | 22.5M | 4.6M | 4.4M | 2.6M | 291.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $19K | $17K | $16K | $22K | $0 | $0 | $0 | $0 |
| Research & Development | $6.07M | $7.77M | $5.28M | $7.76M | $10.52M | $10.03M | $9.28M | $7.77M |
| Total Operating Expenses | $12.34M | $14.51M | $4.63M | $18.66M | $16.95M | $16.80M | $16.40M | $16.17M |
| **Operating Income** | -$12.32M | -$14.49M | -$4.62M | -$18.64M | -$16.95M | -$16.80M | -$16.40M | -$16.17M |
| **EBITDA** | -$11.67M | -$13.82M | -$3.93M | -$17.74M | -$16.04M | -$15.88M | -$15.47M | -$15.23M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$11.59M | -$12.75M | -$4.22M | -$14.47M | -$18.13M | -$14.73M | -$14.11M | -$610K |
| Basic EPS | -$0.37 | -$0.41 | -$0.14 | -- | -$0.69 | -$0.56 | -$1.41 | -- |
| **Diluted EPS** | -$0.37 | -$0.41 | -$0.14 | -- | -$0.69 | -$0.56 | -$1.41 | -- |
| Basic Shares Outstanding | 31.1M | 31.1M | 31.0M | -- | 26.2M | 26.1M | 10.0M | -- |
| Diluted Shares Outstanding | 31.1M | 31.1M | 31.0M | -- | 26.2M | 26.1M | 10.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.42M | $48.28M | $35.93M | $57.62M | $56.03M |
| Short-Term Investments | -- | -- | $0 | $40.94M | $0 |
| **Cash & Short-Term Investments** | $16.42M | $48.28M | $35.90M | $98.60M | $56.00M |
| Accounts Receivable, Net | -- | -- | -- | $626K | $483K |
| Other Current Assets | $0 | $584K | $195K | $101K | $275K |
| **Total Current Assets** | $23.27M | $58.96M | $71.20M | $102.6M | $60.19M |
| Property, Plant & Equipment, Net | $12.89M | $21.29M | $25.34M | $51.36M | $12.37M |
| Other Non-Current Assets | $19K | $105K | $215K | $283K | $176K |
| **Total Non-Current Assets** | $27.95M | $38.88M | $48.28M | $78.21M | $36.51M |
| **Total Assets** | $51.22M | $97.84M | $119.5M | $180.8M | $96.70M |
| Accounts Payable | $2.94M | $1.45M | $1.25M | $1.37M | $5.19M |
| Deferred Revenue (Current) | $43K | $0 | $0 | $799K | $1.66M |
| **Total Current Liabilities** | $13.97M | $13.15M | $12.67M | $18.05M | $14.54M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $176K |
| Other Non-Current Liabilities | $8.10M | $5.05M | $0 | -- | -- |
| **Total Non-Current Liabilities** | $31.66M | $33.94M | $39.90M | $35.48M | $21.78M |
| **Total Liabilities** | $45.63M | $47.09M | $52.57M | $53.53M | $36.33M |
| **Total Debt (incl. Leases)** | $28.89M | $33.64M | $37.67M | $37.09M | $22.73M |
| Common Stock | $3.0K | $1.0K | $1.0K | $4.0K | $0 |
| Retained Earnings | -$358.6M | -$297.1M | -$244.3M | -$173.3M | -$115.1M |
| Accumulated Other Comp. Income | -- | -- | $0 | $1.0K | $0 |
| **Total Stockholders' Equity** | $5.59M | $25.65M | $66.91M | $127.3M | -$111.5M |
| Total Equity | $5.59M | $25.65M | $66.91M | $127.3M | -$111.5M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.55M | $6.46M | $8.94M | $16.42M | $12.24M | $21.58M | $33.80M | $48.28M |
| **Cash & Short-Term Investments** | $5.55M | $6.46M | $8.94M | $16.42M | $12.24M | $21.58M | $33.80M | $48.28M |
| Other Current Assets | $1.0K | $288K | -- | $0 | $0 | $0 | $0 | $584K |
| **Total Current Assets** | $9.52M | $13.01M | $14.79M | $23.27M | $18.16M | $32.52M | $45.21M | $58.96M |
| Property, Plant & Equipment, Net | $10.77M | $11.43M | $12.10M | $12.89M | $18.69M | $19.59M | $20.53M | $21.29M |
| Other Non-Current Assets | $0 | $0 | $5.0K | $19K | $34K | $52K | $76K | $105K |
| **Total Non-Current Assets** | $18.84M | $20.10M | $23.45M | $27.95M | $34.53M | $36.02M | $37.56M | $38.88M |
| **Total Assets** | $28.36M | $33.10M | $38.24M | $51.22M | $52.69M | $68.54M | $82.78M | $97.84M |
| Accounts Payable | $2.40M | $2.25M | $1.05M | $2.94M | $1.77M | $1.02M | $1.56M | $1.45M |
| Deferred Revenue (Current) | $60K | $11K | $27K | $43K | -- | -- | -- | $0 |
| **Total Current Liabilities** | $17.59M | $15.77M | $14.27M | $13.97M | $12.03M | $9.99M | $10.73M | $13.15M |
| Other Non-Current Liabilities | $8.00M | $8.00M | $8.16M | $8.10M | $7.57M | $7.57M | $6.56M | $5.05M |
| **Total Non-Current Liabilities** | $20.37M | $20.74M | $21.41M | $31.66M | $32.54M | $33.90M | $34.19M | $33.94M |
| **Total Liabilities** | $37.96M | $36.51M | $35.68M | $45.63M | $44.56M | $43.89M | $44.92M | $47.09M |
| **Total Debt (incl. Leases)** | $15.27M | $16.23M | $19.14M | $28.89M | $30.12M | $31.31M | $32.45M | $33.64M |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$387.1M | -$3.40M | -$362.8M | -$358.6M | -$344.1M | -$326.0M | -$311.2M | -$297.1M |
| **Total Stockholders' Equity** | -$9.60M | -$3.40M | $2.56M | $5.59M | $8.12M | $24.65M | $37.86M | $25.65M |
| Total Equity | -$9.60M | -$3.40M | $2.56M | $5.59M | $8.12M | $24.65M | $37.86M | $25.65M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$61.44M | -$52.79M | -$71.06M | -$58.21M | -$55.32M |
| Depreciation & Amortization | $3.64M | $3.84M | $3.56M | $1.40M | $769K |
| Stock-Based Compensation | $5.71M | $1.75M | $9.67M | $16.39M | $2.29M |
| Change in Receivables | -- | -- | -- | -$131K | -$395K |
| Change in Payables | $1.74M | $797K | -$290K | $186K | -$617K |
| **Operating Cash Flow** | -$43.44M | -$41.40M | -$52.40M | -$34.90M | -$34.63M |
| Capital Expenditure | -$196K | -$26K | -$12.04M | -$41.37M | -$5.54M |
| **Free Cash Flow** | -$43.64M | -$41.42M | -$64.43M | -$76.27M | -$40.18M |
| **Investing Cash Flow** | -$184K | $34K | $30.08M | -$81.96M | -$5.54M |
| Common Stock Issued | -- | $1.81M | $512K | $728K | $0 |
| **Financing Cash Flow** | $11.76M | $53.73M | $779K | $118.6M | $68.44M |
| **Net Change in Cash** | -$31.87M | $12.37M | -$21.54M | $1.70M | $28.26M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.59M | -$12.75M | -$4.22M | -$14.47M | -$18.13M | -$14.73M | -$14.11M | -$610K |
| Depreciation & Amortization | $650K | $667K | $688K | $893K | $904K | $914K | $926K | $937K |
| Stock-Based Compensation | $961K | $1.05M | $1.31M | $1.43M | $1.55M | $1.53M | $1.20M | $605K |
| Change in Payables | $156K | $1.22M | -$1.89M | $1.17M | $750K | -$537K | $357K | $1.24M |
| **Operating Cash Flow** | -$6.73M | -$14.25M | -$7.48M | -$6.88M | -$9.45M | -$13.07M | -$14.05M | -$13.50M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | -$196K | $0 | -$11K |
| **Free Cash Flow** | -- | -- | -- | -$6.88M | -$9.45M | -$13.27M | -$14.05M | -$13.52M |
| **Investing Cash Flow** | $0 | $0 | $114K | $0 | $0 | -$184K | $0 | -$11K |
| **Financing Cash Flow** | $5.82M | $9.68M | -$118K | $11.04M | $124K | $1.01M | -$414K | $51.29M |
| **Net Change in Cash** | -$907K | -$4.57M | -$7.49M | $4.17M | -$9.32M | -$12.25M | -$14.46M | $37.77M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -312631.8% | -- | -3620.7% | -1448.5% | -1464.9% |
| **Net Profit Margin** | -279263.6% | -- | -2774.6% | -1358.1% | -2003.6% |
| Return on Equity (ROE) | -1099.3% | -205.8% | -106.2% | -45.7% | -- |
| Return on Assets (ROA) | -119.9% | -54.0% | -59.5% | -32.2% | -57.2% |
| Current Ratio | 1.67x | 4.49x | 5.62x | 5.68x | 4.14x |
| Quick Ratio | 1.18x | 3.67x | 2.83x | 5.50x | 3.88x |
| Debt to Equity | 5.17x | 1.31x | 0.56x | 0.29x | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -40.2% | +55.2% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -67652.7% | -99434.5% | -149994.7% | -312631.8% | -- | -- | -- | -- |
| **Net Profit Margin** | -58140.5% | -90116.4% | -135650.0% | -279263.6% | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -2009.6% | -1099.3% | -585.9% | -236.6% | -144.7% | -205.8% |
| Return on Assets (ROA) | -151.7% | -149.7% | -134.8% | -119.9% | -90.3% | -85.1% | -66.2% | -54.0% |
| Current Ratio | 0.54x | 0.83x | 1.04x | 1.67x | 1.51x | 3.26x | 4.22x | 4.49x |
| Quick Ratio | 0.32x | 0.41x | 0.63x | 1.18x | 1.02x | 2.16x | 3.15x | 3.67x |
| Debt to Equity | -- | -- | 7.46x | 5.17x | 3.71x | 1.27x | 0.86x | 1.31x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
